Covidien launches new pediatric tracheo tubes; Tyrx notches first implant;

 @FierceMedDev: Special Report: 2012's 10 highest-paid Med Tech CEOs. Report | Follow @FierceMedDev

 @MarkHFierce: Luminex won FDA clearance of a new Dx system to help a key GI fecal test reach more patients. More | Follow @MarkHFierce

 @DamianFierce: The Life Tech saga is finally over: Thermo Fisher has inked a $13.6B deal to buy it. Release | Follow @DamianFierce

> Covidien ($COV) is launching new Shiley neonatal and pediatric tracheostomy tubes, saying the new cuffless models improve patient comfort and safety. More

> 2012 Fierce 15 winner Tyrx notched the first implantation of its AigisRx resorbable antibacterial envelope for implantable medical devices. News

> Argon Medical Devices has completed its $362.5 million acquisition of Angiotech's interventional devices business. Item

> Scottish medical device company DySIS Medical has completed about $9.7 million in venture fundraising. Release

> Fast Company takes a long-form look at the two entrepreneurs who came up with the technology that is now Medtronic's ($MDT) much-hyped renal denervation device, Symplicity. Article

> Startup dBMEDx has secured $1.1 million in financing to develop its hand-held 3-D ultrasound scanner. Story

Biotech News

 @FierceBiotech: Sanofi CEO fires surprise torpedo at Alzheimer's drug research. Report | Follow @FierceBiotech

 @RyanMFierce: How much of $TMO buyout of $LIFE depends on LIFE prevailing in DNA sequencing race? Big risk. Report | Follow @RyanMFierce

> FDA questions benefits of GSK's respiratory contender Breo. News

> Royalty Pharma ups Elan offer in battle over shareholder support. More

> Portola rolls out $115 million IPO plan as more biotech outfits go public. Story

Pharma News

 @FiercePharma: Eli Lilly to lay off hundreds in sales as Cymbalta nears edge of patent cliff. Story | Follow @FiercePharma

 @EricPFierce: France's Servier under renewed scrutiny by EMA, this time for heart risks tied to Protelos, its osteoporosis drug. Article | Follow @EricPFierce

> CEO Chris Viehbacher steers Sanofi clear of drugs for Alzheimer's disease. Item

> Royalty Pharma drops $12/share cash offer in lap of Elan shareholders. Article

> FDA taking new look at Avandia risks. More

CRO News

> Absorption Systems reaches into India with partnership. Item

> inVentiv teams with Japanese CRO to tap growing market. Report

> Catalent jumps into ADCs with Redwood deal. Story

> Indian CMO Shasun inks Alzheimer's deal with Debiopharm. Article

> Bristol-Myers picks Quintiles for central lab work. More

Biotech IT News

> Chicago's elite back global hub of biomedical data. Item

> J&J, Roche and others back tech platform to bolster translational drug research. Article

> Eric Perakslis leaves top IT job at FDA. Report

> Elsevier scoops up startup Mendeley in controversial bet on open science. Story

> Accelrys, IBM, others spotlight new tech to back pharma R&D. Article

> Study taps web software in novel clinical and genetic research of infants. More